Cohen Fredric J. 4
4 · Strongbridge Biopharma plc · Filed Jan 8, 2021
Insider Transaction Report
Form 4
Cohen Fredric J.
Chief Medical Officer
Transactions
- Award
Ordinary Shares
2021-01-07+181,000→ 218,934 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units, which vest in full on January 7, 2023, provided the Reporting Person is employed by the Issuer on such date. Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.